Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
And in our report of prostacyclin, the \"prostacyclin\" means the drugs used for the treatment of pulmonary arterial hypertension.
The report offers detailed coverage of Prostacyclin industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Prostacyclin by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Prostacyclin market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2028.
First, this report covers the present status and the future prospects of the global Prostacyclin market for 2015-2028.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
At the same time, we classify Prostacyclin according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market by Order Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Market by Application
For Injection
For Oral
For Inhalation
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Prostacyclin market for the forecast period 2020 - 2028?
• What are the driving forces in the Prostacyclin market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Prostacyclin industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?